Cleopatra Hospital CoCAI:CLHO -1.18%88 ROA % is 4.45% as of Mar. 2026, which is 57% below its 10-year median of 10.45. GuruFocus rates CAI:CLHO with a GF Score™ of 88/100 and a GF Value™ of E£13.82 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 686 Healthcare Providers & Services companies, Cleopatra Hospital Co ranks better than 78.72% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Cleopatra Hospital Co's annualizedNet Income for the quarter that ended in Mar. 2026 was E£472 Mil.
Cleopatra Hospital Co's average Total Assets over the quarter that ended in Mar. 2026 was E£10,613 Mil. Therefore, Cleopatra Hospital Co's annualized ROA % for the quarter that ended in Mar. 2026 was 4.45%.
The historical rank and industry rank for Cleopatra Hospital Co's ROA % or its related term are showing as below:
CAI:CLHO'
s ROA % Range Over the Past 10 Years
Min: 5.96 Med: 10.45 Max: 13.39
Current: 7.53
During the past 11 years, Cleopatra Hospital Co's highest ROA % was 13.39%. The lowest was 5.96%. And the median was 10.45%.
CAI:CLHO's ROA % is ranked better than 78.72% of 686
companies
in the Healthcare Providers & Services industry
Industry Median: 1.75
vs CAI:CLHO: 7.53
Cleopatra Hospital Co (CAI:CLHO) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Cleopatra Hospital Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cleopatra Hospital Co ROA % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cleopatra Hospital Co's ROA % distribution charts can be found below:
* The bar in red indicates where Cleopatra Hospital Co's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Cleopatra Hospital Co (CAI:CLHO) has a ROA % of 4.45% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Cleopatra Hospital Co and its competitors. This is 57% below median its historical median of 10.45. Over the past decade, Cleopatra Hospital Co's ROA % has ranged from 5.96 to 13.39. According to the industry distribution chart, Cleopatra Hospital Co ranks #146 out of 686 companies in the Healthcare Providers & Services industry, placing it in the top 21.3%.
Is Cleopatra Hospital Co's ROA % too high?
Cleopatra Hospital Co's current ROA % of 4.45% is 57% below median its 10-year median of 10.45. Over the past 10 years, this metric has ranged from a low of 5.96 to a high of 13.39. The Healthcare Providers & Services industry median ROA % is 1.75. Cleopatra Hospital Co's value of 4.45% is 154.3% above this industry median. Based on the distribution chart, Cleopatra Hospital Co ranks #146 out of 686 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Cleopatra Hospital Co has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cleopatra Hospital Co's ROA % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Cleopatra Hospital Co ranks #146 out of 686 companies for ROA %. This places Cleopatra Hospital Co in the top 21% of its industry — outperforming the majority of peers. The industry median ROA % is 1.75. Cleopatra Hospital Co's value of 4.45% is 154.3% above this benchmark. Historically, Cleopatra Hospital Co's own ROA % has ranged from 5.96 to 13.39 over the past decade. While the company's 10-year median is 10.45 vs. the industry median of 1.75, Cleopatra Hospital Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.75, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cleopatra Hospital Co's current ROA % of 4.45% is 154.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Cleopatra Hospital Co and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cleopatra Hospital Co's current ROA % is 4.45%, which is 57% below median its own 10-year median of 10.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cleopatra Hospital Co stock overvalued right now?
Based on GuruFocus' analysis, Cleopatra Hospital Co (CAI:CLHO) is currently considered Modestly Overvalued. The stock's GF Value™ is E£13.82, compared to a current price of E£16.80 — trading 21.6% above its estimated fair value. The current ROA % is 4.45%, which is 57% below median its 10-year median of 10.45 and 154.3% above the Healthcare Providers & Services industry median of 1.75. Cleopatra Hospital Co's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Cleopatra Hospital Co (CAI:CLHO), the current ROA % is 4.45% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cleopatra Hospital Co (CAI:CLHO) Overvalued in 2026?
Based on GuruFocus' analysis, Cleopatra Hospital Co stock appears to be overvalued.
The current stock price of E£16.80 is trading 21.6% above its estimated GF Value™ of E£13.82.
GuruFocus considers Cleopatra Hospital Co to be Modestly Overvalued.
Key valuation signals for CAI:CLHO:
ROA %: 4.45% (57% below median its 10-year median of 10.45)
GF Value™: E£13.82 vs. price of E£16.80 (21.6% above fair value)
Industry Position: 154.3% above the Healthcare Providers & Services median (#146 of 686)
No single metric tells the full story. See the CAI:CLHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cleopatra Hospital Co establishes a private hospital to provide modern health and medical services, in addition to medical care for inpatients. The company's segments include Cleopatra Hospital Company, Cairo Specialised Hospital, Nile Badrawy Hospital, Al Shrouk Hospital, CHG Medical Services, CHG Pharma for Pharmacy Management, CHG for Hospitals Company, Queens Hospital, ElKateb Hospital, Bedaya El Gedida Company for Medical Centers and Hospitals, CHG SKY Hospital, and Cleopatra Heaven.
88GF Score
Get the complete analysis for CAI:CLHO
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAI:CLHO has been successfully added to your 
